Evidence map›Paper›PMID 27749818›Full record

ArticleNature2016

Single-cell RNA-seq identifies a PD-1

Yong Yu, Jason C H Tsang, Cui Wang, Simon Clare, Juexuan Wang, Xi Chen, Cordelia Brandt, Leanne Kane, Lia S Campos, Liming Lu and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 199 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
199citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

199 citing papers in PubMed, 1 synthesis or guideline pooled it, 303 citations in OpenAlex.

  1. Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review.International journal of molecular sciences · 2020
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. ILC2s and their immune checkpoints in the antitumor response.Journal for immunotherapy of cancer · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Modulating the PD-1-FABP5 axis in ILC2s to regulate adipose tissue metabolism in obesity.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  14. PD-1Journal for immunotherapy of cancer · 2025
    Article
  15. Article
  16. Single-cell Technology in Stem Cell Research.Current stem cell research & therapy · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Review

139 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Yong YuWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Jason C H TsangWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Cui WangWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Simon ClareWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Juexuan WangWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Xi ChenWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Cordelia BrandtWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Leanne KaneWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Lia S CamposWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Liming LuShanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Gabrielle T BelzThe Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria 3052, Australia.
Andrew N J McKenzieMedical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK.
Sarah A TeichmannWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Gordon DouganWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Pentao LiuWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Wellcome Sanger Institute · GBAddenbrooke's Hospital · GBEuropean Bioinformatics Institute · GBMedical Research Council · GBPrince of Wales Hospital · CNShanghai Academy of Agricultural Sciences · CNUniversity of Melbourne · AU

Funding

Medical Research Council MC_U105178805Wellcome Trust 098051Wellcome Trust 100963/Z/13/Z
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) functionally resemble T lymphocytes in cytotoxicity and cytokine production but lack antigen-specific receptors, and they are important regulators of immune responses and tissue homeostasis. ILCs are generated from common lymphoid progenitors, which are subsequently committed to innate lymphoid lineages in the α-lymphoid progenitor, early innate lymphoid progenitor, common helper innate lymphoid progenitor and innate lymphoid cell progenitor compartments. ILCs consist of conventional natural killer cells and helper-like cells (ILC1, ILC2 and ILC3). Despite recent advances, the cellular heterogeneity, developmental trajectory and signalling dependence of ILC progenitors are not fully understood. Here, using single-cell RNA-sequencing (scRNA-seq) of mouse bone marrow progenitors, we reveal ILC precursor subsets, delineate distinct ILC development stages and pathways, and report that high expression of programmed death 1 (PD-1

Indexed as

Base SequenceCell LineageImmunity, InnateSingle-Cell AnalysisAnimalsAntibodiesCell DifferentiationCell SeparationCytokinesDisease Models, AnimalHumansImmunotherapyInfluenza, HumanKiller Cells, NaturalLymphocyte ActivationLymphocytesAntibodiesBcl11b protein, mouseCytokinesPdcd1 protein, mouseProgrammed Cell Death 1 ReceptorReceptors, InterleukinRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID27749818
OpenAlexW2525469791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.